Preclinical evaluation of the efficacy, pharmacokinetics and immunogenicity of JS-001, a programmed cell death protein-1 (PD-1) monoclonal antibody

Por Fu, Jie, Wang, Fang, Dong, Li-hou, Zhang, Jing, Deng, Cheng-lian, Wang, Xue-li, Xie, Xin-yao, Zhang, Jing, Deng, Ruo-xian, Zhang, Li-bo, Wu, Hai, Feng, Hui, Chen, Bo, Song, Hai-feng
Publicado no Acta Pharmacol Sin (2017)